Sangrix Inc. Calls EGM for 10-for-1 Share Consolidation to Meet Nasdaq Bid Price
Sangrix Inc. is holding an Extraordinary General Meeting (EGM) on November 3, 2026, to vote on a 10-for-1 share consolidation. This action is intended to help the company maintain its listing on the Nasdaq Capital Market by increasing the bid price of its Class A Ordinary Shares. The company has previously undertaken two reverse stock splits/consolidations within the last year, and this new consolidation is proposed to avoid immediate delisting. Shareholders will also vote on amendments to the company's articles of association and the potential adjournment of the meeting.
Key Highlights
- Sangrix Inc. announces Extraordinary General Meeting (EGM) on November 3, 2026, to vote on a 10-for-1 share consolidation.
- The share consolidation aims to increase the bid price of Class A Ordinary Shares to meet Nasdaq listing requirements.
- The company has previously undergone a 60-for-1 reverse stock split and a 5-for-1 share consolidation in the past year.
- Proposal One: Approve a 10-for-1 share consolidation, effective November 13, 2026.
- Proposal Two: Amend and restate the memorandum and articles of association to reflect the share consolidation.
- Proposal Three: Adjourn the meeting if necessary to solicit further proxies.
Price Impact
More from BTOG
SANGRIX INC. Completes Dogecoin Share Redemption, Cancels 66,668 Shares
SANGRIX Rebrands, Launches New Website and Logo for AI Focus
BIT ORIGIN Shareholders Approve 5-for-1 Reverse Split & Name Change to SANGRIX INC.